ATE305478T1 - Topoisomerase-ii inhibitoren - Google Patents

Topoisomerase-ii inhibitoren

Info

Publication number
ATE305478T1
ATE305478T1 AT99961115T AT99961115T ATE305478T1 AT E305478 T1 ATE305478 T1 AT E305478T1 AT 99961115 T AT99961115 T AT 99961115T AT 99961115 T AT99961115 T AT 99961115T AT E305478 T1 ATE305478 T1 AT E305478T1
Authority
AT
Austria
Prior art keywords
glu
leu
lys
gln
topoisomerase
Prior art date
Application number
AT99961115T
Other languages
English (en)
Inventor
Serge Fermandjian
Valerie Frere-Gallois
Frederic Troalen
Original Assignee
Lafon Labor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lafon Labor filed Critical Lafon Labor
Application granted granted Critical
Publication of ATE305478T1 publication Critical patent/ATE305478T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/90—Isomerases (5.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Peptides Or Proteins (AREA)
AT99961115T 1998-12-22 1999-12-20 Topoisomerase-ii inhibitoren ATE305478T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9816264A FR2787454B1 (fr) 1998-12-22 1998-12-22 Inhibiteur de la topoisomerase ii
PCT/FR1999/003208 WO2000037499A1 (fr) 1998-12-22 1999-12-20 Inhibiteur de la topoisomerase ii

Publications (1)

Publication Number Publication Date
ATE305478T1 true ATE305478T1 (de) 2005-10-15

Family

ID=9534347

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99961115T ATE305478T1 (de) 1998-12-22 1999-12-20 Topoisomerase-ii inhibitoren

Country Status (8)

Country Link
US (1) US6562788B1 (de)
EP (1) EP1141006B1 (de)
JP (1) JP2002534358A (de)
AT (1) ATE305478T1 (de)
AU (1) AU1783900A (de)
DE (1) DE69927524D1 (de)
FR (1) FR2787454B1 (de)
WO (1) WO2000037499A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104356206B (zh) * 2011-05-06 2017-07-14 上海医药工业研究院 Hrp5类似物及其制备方法

Also Published As

Publication number Publication date
AU1783900A (en) 2000-07-12
FR2787454A1 (fr) 2000-06-23
DE69927524D1 (de) 2006-02-09
JP2002534358A (ja) 2002-10-15
EP1141006A1 (de) 2001-10-10
FR2787454B1 (fr) 2002-02-15
EP1141006B1 (de) 2005-09-28
US6562788B1 (en) 2003-05-13
WO2000037499A1 (fr) 2000-06-29

Similar Documents

Publication Publication Date Title
EP1531791A4 (de) PRûVENTION UND VERRINGERUNG VON BLUTVERLUST
ATE368053T1 (de) Antimikrobielle peptide
ATE338771T1 (de) Antagonisten des intestinotrophen glp-2 peptides
AU1633200A (en) Human parathyroid hormone modifications, preparation and use
EP1803733A3 (de) Behandlung von Entzündungen
ATE177757T1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
NO942553D0 (no) Ny humanproteaseinhibitor av Kunitz-type og varianter derav
EP2011510A3 (de) Pharmazeutische Zusammensetzungen, die immunologisch aktive Herpes simplex Virus Proteinfragmente enthalten
WO2002048183A3 (en) Compositions of peptide crystals
MXPA02000465A (es) Derivados ciclopeptidicos como inhibidores de la integrina alfav beta6.
WO2004014937A3 (en) Thrombin peptide derivatives
DE602004028266D1 (de) Angiogene peptide und ihre verwendungen
WO2001027136A3 (fr) Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire
DE69927524D1 (de) Topoisomerase-ii inhibitoren
AU2865801A (en) Therapeutic peptides
GB2357507A (en) Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants
WO2004000870A3 (en) Two synthetic peptides for treatment and prevention of cancers
EP1225184A4 (de) Menschliche antithrombin-varianten
DE60036676D1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
ATE46173T1 (de) Pharmakologisch aktive peptide.
CA2247998A1 (en) Fragments of cr1 and their use
CY1115911T1 (el) Τροποποιημενα πολυπεπτιδια περιοχης kunitz και η χρηση τους στην μειωση της ισχαιμιας ή της εκκινησης μιας συστημικης φλεγμονωδους ανταποκρισης που σχετιζεται με μια χειρουργικη επεμβαση
DK1158050T3 (da) Human cysteinyl-leukotrienreceptor (CysLT2)
WO2003000718A3 (en) Polypeptides comprising t cell epitopes from alpha-fodrin and the uses thereof in treatment of sjögren's syndrome
TH56074A3 (th) ตัวยับยั้ง อัลฟาv เบตา6 อินทีกริน

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties